Puma Biotechnology reported $260M in Assets for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acceleron Pharma XLRN:US $ 836.05M 39.74M
Agios Pharmaceuticals AGIO:US $ 1874.6M 613.83M
Alexion Pharmaceuticals ALXN:US $ 18650.2M 547.2M
Alnylam Pharmaceuticals ALNY:US $ 3509.43M 254.16M
Amgen AMGN:US $ 59773M 2766M
Arena Pharmaceuticals ARNA:US $ 1084.66M 99.28M
Array Technologies Inc ARRY:US 622.32M 39.04M
Biogen BIIB:US $ 24470.4M 615.7M
Biomarin Pharmaceutical BMRN:US $ 5898.5M 93.44M
Bluebird Bio BLUE:US $ 1454.46M 182.82M
Cerulean Pharma CERU:US $ 14.82M 4.3M
Clovis Oncology CLVS:US $ 572.23M 23.39M
Daiichi Sankyo 4568:JP Y 2062470M 22708M
Esperion Therapeutics ESPR:US $ 280.46M 1.86M
Exelixis EXEL:US $ 2367.27M 176.73M
Gilead Sciences GILD:US $ 67984M 492M
Glaxosmithkline GSK:US $ 77011M 1068M
Intercept Pharmaceuticals ICPT:US $ 523.22M 3.11M
Macrogenics MGNX:US $ 425.91M 9.53M
Mirati Therapeutics MRTX:US $ 1355.7M 25.14M
Moderna Inc MRNA:US 16.15B 3.46B
Novartis NOVN:VX SF 124015M 2263M
Ptc Therapeutics PTCT:US $ 2058.67M 53.27M
Puma Biotechnology PBYI:US $ 260M 1.34M
Regeneron Pharmaceuticals REGN:US $ 21485.9M 3713.7M
Sangamo Biosciences SGMO:US $ 835.36M 41.73M
Sarepta Therapeutics SRPT:US $ 2759.07M 6.16M
Seattle Genetics SGEN:US $ 3952.16M 9.17M
Spectrum Pharmaceuticals SPPI:US $ 175.04M 3.96M
Takeda 4502:JP Y 12657234M 255059M
Tg Therapeutics TGTX:US $ 481.4M 67.3M
Ultragenyx Pharmaceutical RARE:US $ 1512.44M 85.32M
Vanda Pharmaceuticals VNDA:US $ 567.64M 24.45M
Vertex Pharmaceuticals VRTX:US $ 12221.69M 106.63M
YTE INCY:US $ 3904.62M 243.19M